Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001612
Filing Date
2025-08-07
Accepted
2025-08-07 16:18:15
Documents
76
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctso-20250630x10q.htm   iXBRL 10-Q 1804782
2 EX-31.1 ctso-20250630xex31d1.htm EX-31.1 16519
3 EX-31.2 ctso-20250630xex31d2.htm EX-31.2 16528
4 EX-32.1 ctso-20250630xex32d1.htm EX-32.1 7835
5 EX-32.2 ctso-20250630xex32d2.htm EX-32.2 7833
  Complete submission text file 0001410578-25-001612.txt   8972109

Data Files

Seq Description Document Type Size
6 EX-101.SCH ctso-20250630.xsd EX-101.SCH 61621
7 EX-101.CAL ctso-20250630_cal.xml EX-101.CAL 72984
8 EX-101.DEF ctso-20250630_def.xml EX-101.DEF 224649
9 EX-101.LAB ctso-20250630_lab.xml EX-101.LAB 489042
10 EX-101.PRE ctso-20250630_pre.xml EX-101.PRE 407831
79 EXTRACTED XBRL INSTANCE DOCUMENT ctso-20250630x10q_htm.xml XML 1822303
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)